A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668].

Source:http://linkedlifedata.com/resource/pubmed/id/16448552

Download in:

View as

General Info

PMID
16448552